Published in Neuron on April 19, 2007
Assessing spinal axon regeneration and sprouting in Nogo-, MAG-, and OMgp-deficient mice. Neuron (2010) 2.88
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci (2008) 1.96
MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci (2010) 1.86
Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci (2008) 1.66
The reticulons: a family of proteins with diverse functions. Genome Biol (2007) 1.62
Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ (2009) 1.37
Reassessment of corticospinal tract regeneration in Nogo-deficient mice. J Neurosci (2009) 1.31
Regenerative growth of corticospinal tract axons via the ventral column after spinal cord injury in mice. J Neurosci (2008) 1.30
Nogo-66 receptor antagonist peptide (NEP1-40) administration promotes functional recovery and axonal growth after lateral funiculus injury in the adult rat. Neurorehabil Neural Repair (2007) 1.23
Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol (2011) 1.18
Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol (2011) 1.12
Genetic dissection of axon regeneration via in vivo electroporation of adult mouse sensory neurons. Nat Commun (2011) 1.12
White matter inhibitors in CNS axon regeneration failure. Exp Neurol (2007) 1.10
Assessment of functional recovery and axonal sprouting in oligodendrocyte-myelin glycoprotein (OMgp) null mice after spinal cord injury. Mol Cell Neurosci (2008) 1.06
A multi-domain fragment of Nogo-A protein is a potent inhibitor of cortical axon regeneration via Nogo receptor 1. J Biol Chem (2011) 0.97
Functional outcome is impaired following traumatic brain injury in aging Nogo-A/B-deficient mice. Neuroscience (2009) 0.89
Effects of PTEN and Nogo Codeletion on Corticospinal Axon Sprouting and Regeneration in Mice. J Neurosci (2015) 0.88
Comprehensive Corticospinal Labeling with mu-crystallin Transgene Reveals Axon Regeneration after Spinal Cord Trauma in ngr1-/- Mice. J Neurosci (2015) 0.82
Heterodimerization of p45-p75 modulates p75 signaling: structural basis and mechanism of action. PLoS Biol (2014) 0.82
Axon regeneration in young adult mice lacking Nogo-A/B. Neuron (2003) 4.23
Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature (2002) 3.33
Lack of enhanced spinal regeneration in Nogo-deficient mice. Neuron (2003) 3.22
Axonal regeneration in the rat spinal cord produced by an antibody against myelin-associated neurite growth inhibitors. Nature (1990) 3.22
Recovery from spinal cord injury mediated by antibodies to neurite growth inhibitors. Nature (1995) 2.93
Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci (2004) 2.67
False resurrections: distinguishing regenerated from spared axons in the injured central nervous system. J Comp Neurol (2003) 2.34
Systemic deletion of the myelin-associated outgrowth inhibitor Nogo-A improves regenerative and plastic responses after spinal cord injury. Neuron (2003) 2.32
Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci (2004) 2.29
Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci (2003) 2.23
Nogo-A-deficient mice reveal strain-dependent differences in axonal regeneration. J Neurosci (2006) 1.89
The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci (2006) 1.77
Delayed treatment with monoclonal antibody IN-1 1 week after stroke results in recovery of function and corticorubral plasticity in adult rats. J Cereb Blood Flow Metab (2005) 1.48
Regeneration of lesioned corticospinal tract fibers in the adult rat induced by a recombinant, humanized IN-1 antibody fragment. J Neurosci (2000) 1.45
Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol (2006) 1.44
Functional recovery and neuroanatomical plasticity following middle cerebral artery occlusion and IN-1 antibody treatment in the adult rat. Ann Neurol (2002) 1.44
Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol Cell Neurosci (2005) 1.43
Regenerating corticospinal fibers in the Marmoset (Callitrix jacchus) after spinal cord lesion and treatment with the anti-Nogo-A antibody IN-1. Eur J Neurosci (2004) 1.19
No Nogo: now where to go? Neuron (2003) 1.10
Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur J Neurosci (2005) 0.98
Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers. Nature (2009) 6.99
Axon regeneration in young adult mice lacking Nogo-A/B. Neuron (2003) 4.23
Experience-driven plasticity of visual cortex limited by myelin and Nogo receptor. Science (2005) 4.15
Myelin-associated glycoprotein as a functional ligand for the Nogo-66 receptor. Science (2002) 3.50
Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron (2010) 3.44
Memory impairment in transgenic Alzheimer mice requires cellular prion protein. J Neurosci (2010) 3.36
An unbiased expression screen for synaptogenic proteins identifies the LRRTM protein family as synaptic organizers. Neuron (2009) 3.34
Nogo-66 receptor antagonist peptide promotes axonal regeneration. Nature (2002) 3.33
Alzheimer amyloid-β oligomer bound to postsynaptic prion protein activates Fyn to impair neurons. Nat Neurosci (2012) 2.92
Rho kinase inhibition enhances axonal regeneration in the injured CNS. J Neurosci (2003) 2.76
Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron (2004) 2.76
Nogo receptor antagonism promotes stroke recovery by enhancing axonal plasticity. J Neurosci (2004) 2.67
A new role for Nogo as a regulator of vascular remodeling. Nat Med (2004) 2.63
Immune and glial cell factors as pain mediators and modulators. Exp Neurol (2005) 2.30
Blockade of Nogo-66, myelin-associated glycoprotein, and oligodendrocyte myelin glycoprotein by soluble Nogo-66 receptor promotes axonal sprouting and recovery after spinal injury. J Neurosci (2004) 2.29
Can regenerating axons recapitulate developmental guidance during recovery from spinal cord injury? Nat Rev Neurosci (2006) 2.28
Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J Neurosci (2003) 2.23
Regulation of neurogenesis in adult mouse hippocampus by cAMP and the cAMP response element-binding protein. J Neurosci (2002) 2.21
RGM and its receptor neogenin regulate neuronal survival. Nat Cell Biol (2004) 2.14
The Nogo-66 receptor: focusing myelin inhibition of axon regeneration. Trends Neurosci (2003) 2.11
Extracellular regulators of axonal growth in the adult central nervous system. Philos Trans R Soc Lond B Biol Sci (2006) 2.10
Inhibition of SRGAP2 function by its human-specific paralogs induces neoteny during spine maturation. Cell (2012) 2.02
Small proline-rich repeat protein 1A is expressed by axotomized neurons and promotes axonal outgrowth. J Neurosci (2002) 2.01
Localization of Nogo-A and Nogo-66 receptor proteins at sites of axon-myelin and synaptic contact. J Neurosci (2002) 1.96
Genetic variants of Nogo-66 receptor with possible association to schizophrenia block myelin inhibition of axon growth. J Neurosci (2008) 1.96
Toll-like receptor 3 is a potent negative regulator of axonal growth in mammals. J Neurosci (2007) 1.88
Metabotropic glutamate receptor 5 is a coreceptor for Alzheimer aβ oligomer bound to cellular prion protein. Neuron (2013) 1.87
MAG and OMgp synergize with Nogo-A to restrict axonal growth and neurological recovery after spinal cord trauma. J Neurosci (2010) 1.86
Conditioning injury-induced spinal axon regeneration requires signal transducer and activator of transcription 3 activation. J Neurosci (2005) 1.82
Structure and axon outgrowth inhibitor binding of the Nogo-66 receptor and related proteins. EMBO J (2003) 1.78
The Nogo-Nogo receptor pathway limits a spectrum of adult CNS axonal growth. J Neurosci (2006) 1.77
Neogenin mediates the action of repulsive guidance molecule. Nat Cell Biol (2004) 1.77
Rec8 phosphorylation and recombination promote the step-wise loss of cohesins in meiosis. Nature (2006) 1.66
Axonal growth therapeutics: regeneration or sprouting or plasticity? Trends Neurosci (2008) 1.66
Anti-PrPC monoclonal antibody infusion as a novel treatment for cognitive deficits in an Alzheimer's disease model mouse. BMC Neurosci (2010) 1.66
Functional axonal regeneration through astrocytic scar genetically modified to digest chondroitin sulfate proteoglycans. J Neurosci (2007) 1.64
The reticulons: a family of proteins with diverse functions. Genome Biol (2007) 1.62
Regulation of spine morphology and spine density by NMDA receptor signaling in vivo. Proc Natl Acad Sci U S A (2007) 1.58
Truncated soluble Nogo receptor binds Nogo-66 and blocks inhibition of axon growth by myelin. J Neurosci (2002) 1.55
Fibroblast growth factor-inducible-14 is induced in axotomized neurons and promotes neurite outgrowth. J Neurosci (2003) 1.52
Delayed Nogo receptor therapy improves recovery from spinal cord contusion. Ann Neurol (2006) 1.44
Localization of phosphorylated cAMP response element-binding protein in immature neurons of adult hippocampus. J Neurosci (2002) 1.44
The CRMP family of proteins and their role in Sema3A signaling. Adv Exp Med Biol (2007) 1.43
Transgenic inhibition of Nogo-66 receptor function allows axonal sprouting and improved locomotion after spinal injury. Mol Cell Neurosci (2005) 1.43
Genetic reduction of striatal-enriched tyrosine phosphatase (STEP) reverses cognitive and cellular deficits in an Alzheimer's disease mouse model. Proc Natl Acad Sci U S A (2010) 1.42
Clinical significance of the mixing test in laboratory diagnoses of lupus anticoagulant: the fate of the mixing test in integrated lupus anticoagulant test systems. Blood Coagul Fibrinolysis (2012) 1.42
Graphene oxide thin films for flexible nonvolatile memory applications. Nano Lett (2010) 1.40
Identification of a receptor necessary for Nogo-B stimulated chemotaxis and morphogenesis of endothelial cells. Proc Natl Acad Sci U S A (2006) 1.39
ROCK and Rho: biochemistry and neuronal functions of Rho-associated protein kinases. Neuroscientist (2007) 1.38
The N-terminal domain of Nogo-A inhibits cell adhesion and axonal outgrowth by an integrin-specific mechanism. J Neurosci (2008) 1.38
Axon regeneration in the peripheral and central nervous systems. Results Probl Cell Differ (2009) 1.37
Clinical analysis of risk factors related to recurrent chronic subdural hematoma. J Korean Neurosurg Soc (2008) 1.33
LGI1-associated epilepsy through altered ADAM23-dependent neuronal morphology. Mol Cell Neurosci (2009) 1.32
Structural bases for CRMP function in plexin-dependent semaphorin3A signaling. EMBO J (2003) 1.29
Combination of NEP 1-40 treatment and motor training enhances behavioral recovery after a focal cortical infarct in rats. Stroke (2010) 1.25
Targeting the Nogo receptor to treat central nervous system injuries. Nat Rev Drug Discov (2003) 1.25
RanBPM contributes to Semaphorin3A signaling through plexin-A receptors. J Neurosci (2006) 1.24
Alzheimer precursor protein interaction with the Nogo-66 receptor reduces amyloid-beta plaque deposition. J Neurosci (2006) 1.24
Rho-associated kinase II (ROCKII) limits axonal growth after trauma within the adult mouse spinal cord. J Neurosci (2009) 1.22
Endovascular embolization of iatrogenic vertebral artery injury during anterior cervical spine surgery: report of two cases and review of the literature. Spine (Phila Pa 1976) (2006) 1.19
Recovery from chronic spinal cord contusion after Nogo receptor intervention. Ann Neurol (2011) 1.18
Anatomical plasticity of adult brain is titrated by Nogo Receptor 1. Neuron (2013) 1.18
Effects of selective serotonin reuptake inhibitors on GABAergic inhibition in the hippocampus of normal and pilocarpine induced epileptic rats. Brain Res (2010) 1.17
Subcutaneous Nogo receptor removes brain amyloid-beta and improves spatial memory in Alzheimer's transgenic mice. J Neurosci (2006) 1.16
Epileptogenic roles of astroglial death and regeneration in the dentate gyrus of experimental temporal lobe epilepsy. Glia (2006) 1.15
Inosine augments the effects of a Nogo receptor blocker and of environmental enrichment to restore skilled forelimb use after stroke. J Neurosci (2011) 1.14
Nogo-A interacts with the Nogo-66 receptor through multiple sites to create an isoform-selective subnanomolar agonist. J Neurosci (2005) 1.12
Myelin associated inhibitors: a link between injury-induced and experience-dependent plasticity. Exp Neurol (2011) 1.12
Release of MICAL autoinhibition by semaphorin-plexin signaling promotes interaction with collapsin response mediator protein. J Neurosci (2008) 1.12
Reticulon-4A (Nogo-A) redistributes protein disulfide isomerase to protect mice from SOD1-dependent amyotrophic lateral sclerosis. J Neurosci (2009) 1.11
Zinc oxide nanoparticle induced autophagic cell death and mitochondrial damage via reactive oxygen species generation. Toxicol In Vitro (2013) 1.08
Characterization of myelin ligand complexes with neuronal Nogo-66 receptor family members. J Biol Chem (2006) 1.07
Advanced zinc-air batteries based on high-performance hybrid electrocatalysts. Nat Commun (2013) 1.05
The efficacy of the synthetic interbody cage and Grafton for anterior cervical fusion. Spine (Phila Pa 1976) (2009) 1.04
Ibuprofen enhances recovery from spinal cord injury by limiting tissue loss and stimulating axonal growth. J Neurotrauma (2009) 1.03
Spatiotemporal characteristics of astroglial death in the rat hippocampo-entorhinal complex following pilocarpine-induced status epilepticus. J Comp Neurol (2008) 1.03
Cartilage acidic protein-1B (LOTUS), an endogenous Nogo receptor antagonist for axon tract formation. Science (2011) 1.03
Myelin-derived ephrinB3 restricts axonal regeneration and recovery after adult CNS injury. Proc Natl Acad Sci U S A (2012) 1.02
Vps10 family proteins and the retromer complex in aging-related neurodegeneration and diabetes. J Neurosci (2012) 1.02
Antioxidant and antimelanogenic properties of chestnut flower extract. Biosci Biotechnol Biochem (2010) 1.01
Spinal cord injury produced by direct damage during cervical transforaminal epidural injection. Reg Anesth Pain Med (2008) 1.00
Genetic deletion and pharmacological inhibition of Nogo-66 receptor impairs cognitive outcome after traumatic brain injury in mice. J Neurotrauma (2010) 1.00
Beta-amyloid oligomers and cellular prion protein in Alzheimer's disease. J Mol Med (Berl) (2009) 0.99
Limiting multiple sclerosis related axonopathy by blocking Nogo receptor and CRMP-2 phosphorylation. Brain (2012) 0.98
Effect of combined treatment with methylprednisolone and soluble Nogo-66 receptor after rat spinal cord injury. Eur J Neurosci (2005) 0.98
Kernohan's notch phenomenon in chronic subdural hematoma: MRI findings. J Clin Neurosci (2007) 0.98
Regulating axon growth within the postnatal central nervous system. Semin Perinatol (2004) 0.98
Nogo and the Nogo-66 receptor. Prog Brain Res (2002) 0.97